Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition is a research paper published in The Journal of Experimental Medicine (2023). On theSindex it has a DataRank of 0.500. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.500
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: P30 CA016087
National Cancer Institute
Grant: CA49152
National Cancer Institute
Grant: CA244896
National Human Genome Research Institute
Grant: HG010099
NHGRI NIH HHS
Grant: DP2 HG010099
NCI NIH HHS
Grant: R37 CA049152
NCI NIH HHS
Grant: R01 CA049152
National Institutes of Health
Grant: 5R01CA049152-13
SIGNAL TRANSDUCTION BY NON-TRANSMEMBRANE PTPS
National Institutes of Health
Grant: 5P30CA016087-32
Experimental Pathology
National Institutes of Health
Grant: 3DP2HG010099-01S2
In situ functional genomics to understand transcriptional regulation
FWCI
2.49
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals